Bank of America
NVAX icon

Bank of America’s Novavax NVAX Stock Holding History

Bank of America’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$54M Sell
6,637,213
-1,653,452
-20% -$15M ﹤0.01% 1535
2025
Q4 		$55.7M Buy
8,290,665
+5,189,591
+167% +$39.1M ﹤0.01% 1479
2025
Q3 		$26.9M Sell
3,101,074
-34,315
-1% -$267K ﹤0.01% 2322
2025
Q2 		$19.8M Buy
3,135,389
+1,982,302
+172% +$13.1M ﹤0.01% 2563
2025
Q1 		$7.39M Buy
1,153,087
+322,331
+39% +$2.66M ﹤0.01% 3444
2024
Q4 		$6.68M Sell
830,756
-262,096
-24% -$2.53M ﹤0.01% 3311
2024
Q3 		$13.8M Buy
1,092,852
+265,237
+32% +$3.42M ﹤0.01% 2759
2024
Q2 		$10.5M Sell
827,615
-252,489
-23% -$2.54M ﹤0.01% 2902
2024
Q1 		$5.16M Sell
1,080,104
-246,838
-19% -$1.14M ﹤0.01% 3579
2023
Q4 		$6.37M Buy
1,326,942
+208,403
+19% +$1.28M ﹤0.01% 3342
2023
Q3 		$8.1M Sell
1,118,539
-1,066,247
-49% -$8.52M ﹤0.01% 2935
2023
Q2 		$16.2M Sell
2,184,786
-304,856
-12% -$2.4M ﹤0.01% 2229
2023
Q1 		$17.3M Buy
2,489,642
+1,728,021
+227% +$15.9M ﹤0.01% 2271
2022
Q4 		$7.83M Buy
761,621
+457,454
+150% +$8.07M ﹤0.01% 2922
2022
Q3 		$5.54M Sell
304,167
-96,868
-24% -$4.2M ﹤0.01% 3237
2022
Q2 		$20.6M Buy
401,035
+140,577
+54% +$7.28M ﹤0.01% 1998
2022
Q1 		$19.2M Buy
260,458
+188,137
+260% +$16.8M ﹤0.01% 2176
2021
Q4 		$10.3M Sell
72,321
-21,099
-23% -$3.63M ﹤0.01% 2894
2021
Q3 		$19.4M Buy
93,420
+44,952
+93% +$9.91M ﹤0.01% 2209
2021
Q2 		$10.3M Sell
48,468
-37,418
-44% -$6.86M ﹤0.01% 2826
2021
Q1 		$15.6M Buy
85,886
+42,820
+99% +$8.53M ﹤0.01% 2266
2020
Q4 		$4.8M Sell
43,066
-8,094
-16% -$860K ﹤0.01% 3168
2020
Q3 		$5.54M Sell
51,160
-13,803
-21% -$1.68M ﹤0.01% 2820
2020
Q2 		$5.41M Sell
64,963
-20,183
-24% -$772K ﹤0.01% 2760
2020
Q1 		$1.16M Buy
85,146
+73,094
+606% +$618K ﹤0.01% 3918
2019
Q4 		$48K Sell
12,052
-22,353
-65% -$96.9K ﹤0.01% 6271
2019
Q3 		$172K Buy
34,405
+798
+2% +$4.37K ﹤0.01% 5754
2019
Q2 		$196K Sell
33,607
-83,774
-71% -$659K ﹤0.01% 5649
2019
Q1 		$1.29M Buy
117,381
+91,498
+354% +$2.89M ﹤0.01% 4319
2018
Q4 		$952K Buy
25,883
+20,326
+366% +$788K ﹤0.01% 4446
2018
Q3 		$208K Sell
5,557
-20,516
-79% -$578K ﹤0.01% 5464
2018
Q2 		$698K Buy
26,073
+17,460
+203% +$590K ﹤0.01% 4694
2018
Q1 		$361K Buy
8,613
+3,047
+55% +$122K ﹤0.01% 5030
2017
Q4 		$138K Sell
5,566
-13,952
-71% -$340K ﹤0.01% 5590
2017
Q3 		$445K Buy
19,518
+14,192
+266% +$318K ﹤0.01% 5026
2017
Q2 		$122K Buy
5,326
+566
+12% +$11.1K ﹤0.01% 5529
2017
Q1 		$121K Sell
4,760
-4,268
-47% -$117K ﹤0.01% 5537
2016
Q4 		$227K Buy
9,028
+7,007
+347% +$204K ﹤0.01% 5267
2016
Q3 		$83K Sell
2,021
-25,682
-93% -$3.32M ﹤0.01% 5511
2016
Q2 		$4.03M Buy
27,703
+1,259
+5% +$144K ﹤0.01% 2983
2016
Q1 		$2.73M Buy
26,444
+15,528
+142% +$1.67M ﹤0.01% 3308
2015
Q4 		$1.83M Buy
10,916
+3,013
+38% +$464K ﹤0.01% 3878
2015
Q3 		$1.12M Buy
7,903
+2,180
+38% +$489K ﹤0.01% 4245
2015
Q2 		$1.27M Buy
5,723
+2,603
+83% +$458K ﹤0.01% 3893
2015
Q1 		$516K Buy
3,120
+419
+16% +$68K ﹤0.01% 4300
2014
Q4 		$320K Sell
2,701
-2,244
-45% -$235K ﹤0.01% 4982
2014
Q3 		$412K Buy
4,945
+3,101
+168% +$280K ﹤0.01% 4765
2014
Q2 		$170K Sell
1,844
-1,211
-40% -$106K ﹤0.01% 5695
2014
Q1 		$277K Sell
3,055
-245
-7% -$27.4K ﹤0.01% 5144
2013
Q4 		$338K Buy
3,300
+827
+33% +$58.4K ﹤0.01% 5115
2013
Q3 		$156K Buy
2,473
+529
+27% +$29.8K ﹤0.01% 5660
2013
Q2 		$80K Buy
+1,944
New +$84.2K ﹤0.01% 6290

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America's NVAX Position: Q1 2026 in Review

Bank of America reduced its Novavax (NVAX) stake by 20% in Q1 2026, selling an estimated $15M and leaving 6,637,213 shares worth $54M. The position accounts for ﹤0.01% of the portfolio, ranked #1535.

Bank of America first reported a position in NVAX in Q2 2013 and has held it in 52 quarters since. The position peaked at $55.7M in Q4 2025. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Bank of America held 6,637,213 shares of Novavax worth $54M as of Q1 2026.
  • Bank of America sold 1,653,452 Novavax shares in Q1 2026, an estimated $15M.
  • Novavax made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #1535 holding.
  • Bank of America first reported a position in Novavax in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Novavax position peaked at $55.7M in Q4 2025.
  • 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.